In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...